Publication | Closed Access

A high CD34+ cell dose is associated with better disease-free survival in patients with low-risk diseases undergoing peripheral blood stem cell transplantation from HLA-matched related donors

Hla-matched Related DonorsTransplantationMarrow TransplantationLow-risk DiseasesStem Cell TransplantationImmunologyHematologyAutoimmunityGraft SurvivalBlood TransplantationMedicineCell TransplantationBetter Disease-free SurvivalGraft Rejection